Circulating angiogenic factors and the risk of preeclampsia.
about
Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disordersFetal ERAP2 variation is associated with preeclampsia in African Americans in a case-control studyPlacental biomarkers of phthalate effects on mRNA transcription: application in epidemiologic researchSevere intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancyTissue factor and its natural inhibitor in pre-eclampsia and SGAHypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarkerPodocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective studyAngiotensin receptors, autoimmunity, and preeclampsiaVEGF inhibition and renal thrombotic microangiopathyCigarette smoke exposure and angiogenic factors in pregnancy and preeclampsiaThe placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsiaRegulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cellsPre-eclampsia: its pathogenesis and pathophysiolgyAngiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical IntegrationUnderstanding and Managing Pregnancy in Patients with LupusThe imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsiaRegional changes of placental vascularization in preeclampsia: a reviewCombined Screening for Early Detection of Pre-EclampsiaAccuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysisAngiogenic factors in preeclampsia: potential for diagnosis and treatmentInflammation, immunity, and hypertensive end-organ damageTherapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsiaLeukocyte driven-decidual angiogenesis in early pregnancyPathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiologyAn unexpected tail of VEGF and PlGF in pre-eclampsiaA leading role for the immune system in the pathophysiology of preeclampsiaThe renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?Vascular endothelial growth factor-B in physiology and diseaseVascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseasesEpidemiology of preeclampsia: impact of obesityIs inflammation the cause of pre-eclampsia?Innate immunity, decidual cells, and preeclampsiaRole of corin and atrial natriuretic peptide in preeclampsiaA Comprehensive Review of Hypertension in PregnancyThe placenta: a multifaceted, transient organAngiogenic factors in diagnosis, management, and research in preeclampsia.Vascular IL-10: a protective role in preeclampsia.A Dormant Microbial Component in the Development of PreeclampsiaThe decidua-the maternal bed embracing the embryo-maintains the pregnancy
P2860
Q21144276-7FEFECCB-702B-446A-85D2-246F509069FAQ21261491-D57CC1E5-6703-4282-9F52-D24ACC72B806Q23914667-12908321-B7AB-4ED0-8A9E-0C4108606E36Q24304467-450BD83A-1991-4901-925C-54830AE8420CQ24308003-7313D46E-775B-43FA-AFE2-3E526A4D9C90Q24323351-19250454-796E-4CF2-AD44-92FF145055E3Q24595773-BBB11E46-3974-4FEB-9489-4433384BA2D0Q24597867-1F22B7F1-E5DF-499C-AEC1-8D70C85E613BQ24605647-799690F4-9C5E-4B05-99A0-6F917458C199Q24632792-1E951FDF-E5D7-457E-B662-C7F5645AC1EBQ24654029-F1E90024-BD4D-4D28-A3B3-7B4CFC91CF98Q24795491-9FF68570-684F-4B36-8F79-9EE9253DDA67Q24813046-A57A75C4-52C8-4FAB-AC23-3BD33DE43011Q26746841-2343484F-A621-4B47-AADF-F30CCC2191F5Q26796661-A6CFA093-41C6-4E91-891A-69E50B069248Q26798179-E7B066B7-7E9A-434C-971C-910051CDBCA4Q26798193-B4A3593E-F99E-4F97-A3D0-CF0ED2E0CE27Q26798340-F2725E45-1C3A-4A47-9076-3DD2324029D3Q26801503-3755C754-51BB-4EB3-B3E5-EFFF53732A7FQ26825271-FDA4F8F3-0E58-427F-A129-8DC904AC43FAQ26825774-7BBDD86B-6B98-4410-8225-CE7A39714491Q26827525-6D28577E-03A6-483B-8714-2435FD09CDE0Q26849333-455DFA4F-ED4F-4167-AE4D-1CC8896634B1Q26851470-BBBB0ECB-697A-4587-9C66-BAA9540AF481Q26865332-06107399-D753-4B26-B41E-CF182E75675DQ27000996-1026DC7F-D5C7-4711-AF96-7EBE11A665DEQ27003069-542AEA6C-DF5F-4363-ABFF-5AF8DDFDA6BDQ27003301-430E3659-7DAA-4FC8-8D5D-8F9AE3DA2D8BQ27003400-4AB452D2-C3CD-4536-A95C-BDB06BAE0736Q27004077-4D1C36F2-AE73-409F-B675-9A8B071B11A2Q27006497-271ECFEB-8C73-4764-BF99-0125E46CC2E0Q27007059-500F4F9B-45F6-45BC-A1EF-80DE6CA0893CQ27014127-AD9F941D-213D-4B86-BFC5-9FD1ECB0DE22Q27022988-98FA3843-5649-4CD9-8A03-8B6B19081D11Q27495953-8C137AB3-EFC9-447C-80AD-A64E1B244BD6Q27687553-794EE7D6-EF33-405A-BADE-8C7B7EF55C2EQ27692060-0B0F01C3-ECDB-4D67-A00C-7A9579BB2F43Q27693834-8CAD5C31-2A4D-456A-9E28-4ED664F96B8EQ28069689-2AC4467C-3FBA-4643-A164-33CB8D92A4E1Q28069835-607ADED4-6FFC-4AC8-955A-82E6A3BB6B53
P2860
Circulating angiogenic factors and the risk of preeclampsia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Circulating angiogenic factors and the risk of preeclampsia.
@en
Circulating angiogenic factors and the risk of preeclampsia.
@nl
type
label
Circulating angiogenic factors and the risk of preeclampsia.
@en
Circulating angiogenic factors and the risk of preeclampsia.
@nl
prefLabel
Circulating angiogenic factors and the risk of preeclampsia.
@en
Circulating angiogenic factors and the risk of preeclampsia.
@nl
P2093
P356
P1476
Circulating angiogenic factors and the risk of preeclampsia.
@en
P2093
Baha M Sibai
Benjamin P Sachs
Franklin H Epstein
Kee-Hak Lim
Lucinda J England
Ravi Thadhani
Richard J Levine
Sharon E Maynard
P304
P356
10.1056/NEJMOA031884
P407
P577
2004-02-05T00:00:00Z